MBIO Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for Mustang Bio Inc (MBIO.O) is -0.06, compared to its 5-year average forward P/E of -1.93. For a more detailed relative valuation and DCF analysis to assess Mustang Bio Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-1.93

Current PE

-0.06

Overvalued PE

0.82

Undervalued PE

-4.67

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-0.29

Current EV/EBITDA

0.52

Overvalued EV/EBITDA

0.65

Undervalued EV/EBITDA

-1.23

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

Annual

Quarterly

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

MBIO News & Events

Events Timeline

No data

News

5.0

2025-08-28Yahoo Finance

Cascade Prodrug Inc. Names Industry Experts Manuel (Manny) Litchman and Andres Gutierrez to Its Board of Directors

2.0

2025-07-09Benzinga

Calidi Biotherapeutics Stock Jumps 39% After Hours — What's Going On

2.0

2025-07-08TipRanks

3 Penny Stocks to Watch Now, 7/8/25

People Also Watch

Frequently Asked Questions

What is Mustang Bio Inc (MBIO) stock price today?

The current price of MBIO is 1.16 USD — it has increased 1.75 % in the last trading day.

What is Mustang Bio Inc (MBIO)'s business?

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating medical breakthroughs into potential cures for cancers and autoimmune diseases. The Company has partnered with medical institutions to advance the development of chimeric antigen receptor modified T cell (CAR T) therapies. Its pipeline is focused in two core areas: CAR T therapies for autoimmune diseases and hematologic malignancies and CAR T therapies for solid tumors. It is developing a CAR T therapy for hematologic malignancies and autoimmune diseases in partnership with Fred Hutchinson Cancer Center targeting CD20 and for solid tumors in partnership with City of Hope National Medical Center targeting IL13Ra2. It has also partnered with Nationwide Children’s Hospital for a herpes simplex virus type 1 oncolytic virus to enhance the activity of MB-101 for the treatment of patients with high-grade malignant brain tumors.

What is the price predicton of MBIO Stock?

Wall Street analysts forecast MBIO stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MBIO is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Mustang Bio Inc (MBIO)'s revenue for the last quarter?

Mustang Bio Inc revenue for the last quarter amounts to -624.00K USD, decreased -57.17 % YoY.

What is Mustang Bio Inc (MBIO)'s earnings per share (EPS) for the last quarter?

Mustang Bio Inc. EPS for the last quarter amounts to -818000.00 USD, decreased -53.44 % YoY.

What changes have occurred in the market's expectations for Mustang Bio Inc (MBIO)'s fundamentals?

The market is revising No Change the revenue expectations for Mustang Bio, Inc. (MBIO) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -34.46%.

How many employees does Mustang Bio Inc (MBIO). have?

Mustang Bio Inc (MBIO) has 6 emplpoyees as of January 10 2026.

What is Mustang Bio Inc (MBIO) market cap?

Today MBIO has the market capitalization of 8.47M USD.